Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review
Johanna Louise Keeler, Janet Treasure, Mário F. Juruena, et al.
Nutrients (2021) Vol. 13, Iss. 11, pp. 4158-4158
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines update 2023 on the pharmacological treatment of eating disorders
Hubertus Himmerich, Yael Doreen Lewis, Chiara Conti, et al.
The World Journal of Biological Psychiatry (2023) Vol. 24, Iss. 8, pp. 643-706
Open Access | Times Cited: 58
Ketamine and its metabolites: Potential as novel treatments for depression
Kai Zhang, Yitan Yao, Kenji Hashimoto
Neuropharmacology (2022) Vol. 222, pp. 109305-109305
Closed Access | Times Cited: 57
The multisensory mind: a systematic review of multisensory integration processing in Anorexia and Bulimia Nervosa
Giulia Brizzi, Maria Sansoni, Daniele Di Lernia, et al.
Journal of Eating Disorders (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 23
Case report: Intramuscular ketamine or intranasal esketamine as a treatment in four patients with major depressive disorder and comorbid anorexia nervosa
Johanna Louise Keeler, Janet Treasure, Hubertus Himmerich, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 19
Novel treatments for anorexia nervosa: Insights from neuroplasticity research
Johanna Louise Keeler, Carol Kan, Janet Treasure, et al.
European Eating Disorders Review (2023) Vol. 32, Iss. 6, pp. 1069-1084
Open Access | Times Cited: 19
Anorexia nervosa: diagnostic, therapeutic, and risk biomarkers in clinical practice
Hubertus Himmerich, Janet Treasure
Trends in Molecular Medicine (2024) Vol. 30, Iss. 4, pp. 350-360
Open Access | Times Cited: 7
Care pathways for longstanding eating disorders must offer paths to recovery, not managed decline
James Downs
BJPsych Bulletin (2023) Vol. 48, Iss. 3, pp. 177-181
Open Access | Times Cited: 14
Longitudinal changes in brain-derived neurotrophic factor (BDNF) but not cytokines contribute to hippocampal recovery in anorexia nervosa above increases in body mass index
Johanna Louise Keeler, Klaas Bahnsen, Marie‐Louis Wronski, et al.
Psychological Medicine (2024) Vol. 54, Iss. 9, pp. 2242-2253
Open Access | Times Cited: 5
Esketamine in depression: putative biomarkers from clinical research
Jenessa N. Johnston, Carlos A. Zarate, Mark D. Kvarta
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 4
Pharmakotherapie der Essstörungen – ein Update
Tabea Bauman, Ulrich Voderholzer
Der Nervenarzt (2025)
Closed Access
Ketamine as adjuvant treatment in eating disorders: an exploratory study of a case series and retrospective analysis
Paula Jhoana Escobedo-Aedo, Chris Serrand, Sarah Kabani, et al.
Journal of Eating Disorders (2025) Vol. 13, Iss. 1
Open Access
A case series of group-based ketamine-assisted psychotherapy for patients in residential treatment for eating disorders with comorbid depression and anxiety disorders
Reid Robison, Adèle Lafrance, Madeline Brendle, et al.
Journal of Eating Disorders (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 20
Difficulties in retrieving specific details of autobiographical memories and imagining positive future events in individuals with acute but not remitted anorexia nervosa
Johanna Louise Keeler, Georgia Peters-Gill, Janet Treasure, et al.
Journal of Eating Disorders (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 15
Molecular mechanisms underlying the N-methyl-d-aspartate receptor antagonists: Highlighting their potential for transdiagnostic therapeutics
Christina Driver, Timothy N. W. Jackson, Jim Lagopoulos, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 119, pp. 110609-110609
Closed Access | Times Cited: 12
Ketamine and Zinc: Treatment of Anorexia Nervosa Via Dual NMDA Receptor Modulation
Jules Mitchell, Daniel F. Hermens, Maxwell R. Bennett, et al.
CNS Drugs (2023) Vol. 37, Iss. 2, pp. 159-180
Open Access | Times Cited: 7
Perspectives and preliminary experiences of psychedelics for the treatment of eating disorders: A systematic scoping review
Karolina Cuerva, Dean Spirou, A. García Cuerva, et al.
European Eating Disorders Review (2024) Vol. 32, Iss. 5, pp. 980-1001
Open Access | Times Cited: 2
Olanzapine for young PEople with aNorexia nervosa (OPEN): results of a feasibility study
Olena Said, Dominic Stringer, Ece Sengun Filiz, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Effects of psychedelics on neurogenesis and broader neuroplasticity: a systematic review
Rafael Vitor Lima da Cruz, Richardson N. Leão, Thiago C. Moulin
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 2
Olanzapine for young PEople with aNorexia nervosa (OPEN): Results of a feasibility study
Olena Said, Dominic Stringer, Ece Sengun Filiz, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Pharmacotherapeutic strategies for the treatment of anorexia nervosa – novel targets to break a vicious cycle
Millie C. Kirchberg, Claire K. Pinson, Guido Frank
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 17, pp. 2253-2265
Open Access | Times Cited: 1
Novel ketamine and zinc treatment for anorexia nervosa and the potential beneficial interactions with the gut microbiome
Rosiel Elwyn, Jules Mitchell, Michael Kohn, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 148, pp. 105122-105122
Closed Access | Times Cited: 4
Individual differences in the positive outcome from adolescent ketamine treatment in a female mouse model of anorexia nervosa involve drebrin A at excitatory synapses of the medial prefrontal cortex
Rose Temizer, Yi‐Wen Chen, Chiye Aoki
Synapse (2022) Vol. 77, Iss. 1
Open Access | Times Cited: 6
Nutrient Intake and Dietary Inflammatory Potential in Current and Recovered Anorexia Nervosa
Olivia Patsalos, Bethan Dalton, C. Kyprianou, et al.
Nutrients (2021) Vol. 13, Iss. 12, pp. 4400-4400
Open Access | Times Cited: 6
Uma análise dos transtornos alimentares: anorexia nervosa e bulimia
Mariana Teixeira Sgarbi, Maria Clara Teixeira Sgarbi, Eder da Silva Ourofino, et al.
Revista Eletrônica Acervo Médico (2023) Vol. 23, Iss. 2, pp. e12172-e12172
Open Access | Times Cited: 2
Excitatory and inhibitory neurometabolites in anorexia nervosa: A systematic review of proton magnetic resonance spectroscopy studies
Jules Mitchell, Toomas Erik Anijärv, Jacob. L. Levenstein, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 152, pp. 105279-105279
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top